Bharat Biotech To Get $19 Million For Development Of ‘Variant Proof’ Covid Vaccine May 10, 2022May 10, 2022
Covaxin, India’s homegrown COVID jab, ‘highly efficacious’: Study | Coronavirus pandemic News November 12, 2021November 12, 2021
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 3 Clinical Trial Evaluating COVID-19 Vaccine Candidate COVAXIN™ (BBV152) October 27, 2021October 27, 2021
India Covaxin: Some Bhopal slum residents thought they were being vaccinated against Covid-19 but were part of clinical trials February 26, 2021February 26, 2021
India Covaxin: Some Bhopal slum residents thought they were being vaccinated against Covid-19 but were part of clinical trials February 26, 2021February 26, 2021